dyslipidemia การใช้

• Central obesity is associated with glucose intolerance and dyslipidemia.
• Examples include statins in dyslipidemia and gliptins in diabetes.
• Hyperinsulinemia is associated with hypertension, obesity, dyslipidemia, and glucose intolerance.
• "' SCH 900271 "'is a nicotinic acid derivative designed to treat dyslipidemia.
• "' Ralpancizumab "'is a monoclonal antibody designed for the treatment of dyslipidemia.
• "' Evinacumab "'is a monoclonal antibody designed for the treatment of dyslipidemia.
• Obesity has been linked to numerous chronic diseases including cardiovascular disease, dyslipidemia, osteoarthritis and some cancers.
• "' Ezetimibe / simvastatin "'is a drug combination used for the treatment of dyslipidemia.
• Of the components of the cardiometabolic syndrome, only the prevalence of dyslipidemia has declined in the United States.
• PPAR-alpha serves as cellular receptor for fibrates, a class of drugs used in the treatment of dyslipidemia.
• Some hypothesize that CETP inhibitors may still be useful in the treatment of dyslipidemia, though significant caution is warranted.
• Once dyslipidemia becomes a severe problem, an individual's abdominal cavity would generate elevated free fatty acid flux to the liver.
• Riceberry bran oil, a nutraceutical food, may be useful as an alternative food supplement for the alleviation of hyperglycemia and dyslipidemia conditions.
• In 2009, animal trials carried out in India and Malaysia revealed palm tocotrienols improved blood glucose, dyslipidemia and oxidative stress in diabetic rats.
• Finally, dyslipidemia affects the vast majority ( up to 97 % ) of individuals with diabetes and contributes to their elevated risk for cardiovascular disease.
• Researchers first started to focus on abdominal obesity in the 1980s when they realized that it had an important connection to cardiovascular disease, diabetes, and dyslipidemia.
• DOCS screens for the most prevalent diseases in our community including : hypertension, diabetes, dyslipidemia, vision loss, obesity, cervical, and skin cancers.
• Alice H . Lichtenstein said that the consensus is that a low-fat diet is " probably not a good idea " and that it might induce dyslipidemia.
• The risk factors include abdominal obesity, meaning excessive fat tissue in and around the abdomen, atherogenic dyslipidemia which is a blood fat disorder, and elevated blood pressure.
• One Phase I study showed no significant changes in the blood lipids or free fatty acids and another showed that TTA attenuates dyslipidemia in patients with type 2 diabetes mellitus.